N = 80 | ||
Symptom duration (years) mean ± SD (min-max) | 8.93 ± 7.16 (1 - 20) | |
Morning stiffness (min) mean ± SD (min-max) | 43 ± 41.02 (0 - 180) | |
History of night pain % (n) | 62.5% (50) | |
History of peripheral arthritis % (n) | 85% (68) | |
Presence of HLAB 27% (n) | 37.5% (30) | |
Metrological measures mean ± SD (min-max) | Finger floor distance | 15.43 ± 9.11 (0 - 43) |
Dorsal Schober’s | 5 ± 1.08 (3 - 8) | |
Occiput-wall distance | 7.15 ± 2.16 (2 - 14) | |
Chest expansion | 3.98 ± 1.11 (2 - 8) | |
VAS axial mean ± SD (min-max) | 6.81 ± 2.38 (0 - 10) | |
VAS peripheral mean ± SD (min-max) | 5.82 ± 2.92 (0 - 10) | |
BASDAI mean ± SD (min-max) | 5.59 ± 2.05 (0 - 10) | |
BASDAI fatigue > 5% (n) | 60% (48) | |
BASFI mean ± SD (min-max) | 4.89 ± 1.90 (0 - 10) | |
Medications | No therapy %(n) | 12.5% (10) |
NSAID %(n) | 13.8% (11) | |
DMARD + NSAID %(n) | 73.8% (59) | |
Sedim (mm/h) | 18.69 ± 14.55 (4 - 85) | |
CRP (mg/dl) | 1.53 ± 1.39 (0.1 - 6.7) |